Fong T M, Yu H, Strader C D
Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065.
J Biol Chem. 1992 Dec 25;267(36):25668-71.
Two non-peptide substance P antagonists exhibit opposite rank orders of potency for the human and rat neurokinin-1 receptors. CP-96,345 shows selectivity for the human receptor, whereas RP67580 shows selectivity for the rat receptor. Amino acid sequence comparison of the two receptors reveals 22 divergent residues. To elucidate the molecular basis for the species selectivity of these antagonists, divergent residues in the human neurokinin-1 receptor were substituted by the rat homologs. Analysis of mutant receptors revealed that substitution of 2 residues (V116L and I290S) in the transmembrane domain of the human neurokinin-1 receptor is both necessary and sufficient to reproduce the antagonist binding affinities of the rat receptor. The nature of these substitutions and the magnitude of the changes in binding affinity suggest that residues 116 and 290 do not interact directly with the antagonist molecules. The present results support a model in which phylogenetically conserved residues interact directly with the antagonists, while phylogenetically divergent residues affect the local helical packing of the receptor. Such a change in local structure would lead to increased binding affinity for one class of antagonists and decreased affinity for another.
两种非肽类P物质拮抗剂对人和大鼠神经激肽-1受体表现出相反的效价顺序。CP-96,345对人受体具有选择性,而RP67580对大鼠受体具有选择性。两种受体的氨基酸序列比较显示有22个不同的残基。为了阐明这些拮抗剂物种选择性的分子基础,人神经激肽-1受体中的不同残基被大鼠同源物取代。对突变受体的分析表明,人神经激肽-1受体跨膜结构域中的2个残基(V116L和I290S)的取代对于重现大鼠受体的拮抗剂结合亲和力既是必要的也是充分的。这些取代的性质以及结合亲和力变化的程度表明,116和290位残基并不直接与拮抗剂分子相互作用。目前的结果支持一种模型,即系统发育保守的残基直接与拮抗剂相互作用,而系统发育不同的残基影响受体的局部螺旋堆积。局部结构的这种变化将导致对一类拮抗剂的结合亲和力增加,而对另一类拮抗剂的亲和力降低。